Detection of immune-related adverse events among hospitalized patients using large language models.

Authors

null

Virginia H. Sun

Harvard Medical School, Boston, MA

Virginia H. Sun , Julius C. Heemelaar , Ibrahim Hadzic , Vineet K. Raghu , Chia-Yun Wu , Leyre Zubiri , Giselle Alexandra Suero-Abreu , Azin Ghamari , Jessica Wu , Alexandra-Chloé Villani , Jor Sam Ho , Megan J. Mooradian , Meghan E. Sise , Daniel A. Zlotoff , Steven Michael Blum , Michael L. Dougan , Ryan J. Sullivan , Tomas G. Neilan , Kerry Lynn Reynolds , Molly Fisher Thomas

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics—Immunotherapy

Sub Track

Other Checkpoint Inhibitors (Non-PD1/PDL1, Monotherapy, or Combination)

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr 2638)

DOI

10.1200/JCO.2024.42.16_suppl.2638

Abstract #

2638

Poster Bd #

117

Abstract Disclosures

Similar Posters

Poster

2021 ASCO Annual Meeting

Beyond steroids: Immunosuppressants in steroid-refractory/resistant immune related adverse events.

Beyond steroids: Immunosuppressants in steroid-refractory/resistant immune related adverse events.

First Author: Jia Luo

First Author: Amanda Brito

First Author: Yukiko Shimoda Igawa